What does Vicore Pharma Holding AB do?

Vicore Pharma Holding AB (VCRE) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is VCRE's market cap?

Vicore Pharma Holding AB (VCRE) has a market capitalization of approximately $3.27 billion, as of July 22, 2026, based on the most recent share price and shares outstanding.

Does VCRE pay a dividend?

No — Vicore Pharma Holding AB (VCRE) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

VCRE (Vicore Pharma Holding AB) is a recent IPO.

It began trading on July 2, 2026, giving it less than a month of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates — the affected sections are flagged individually so you can tell limited history from missing data.

VCRE

Vicore Pharma Holding AB

NASDAQ·Medical, Pharmaceuticals · Healthcare

$11.62$0.04−0.34%

After hours·$11.63+0.09%

Market cap$3.27B·Market closed·Jul 22 8:00 PM UTC

Price Chart

$11.62−$0.04 (−0.34%)today

−28.49%

Select date range

FromTo

Jul 6, 2026Jul 6, 2026 → Jul 22, 2026· 16 daysJul 22, 2026

Key Metrics

VCRE does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings DateAug 21

Last Report DateMay 6

Reported vs Estimate−$0.04 vs −$0.05

Earnings Surprise+18.8%

Income Statement Flow

PRO

See exactly how VCRE's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for VCRE and 80,000+ other tickers.

About Vicore Pharma Holding AB

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. Its drug development programs include VP01, VP02, VP03, and VP04. The company was founded in 2000 sand is headquartered in Stockholm, Sweden.

CEO: Ahmed Mousa
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Exchange: NASDAQ
Employees: 40
Website: vicorepharma.com

Latest News

News Tab

No recent news available.

Frequently Asked Questions About VCRE

What does Vicore Pharma Holding AB do?: Vicore Pharma Holding AB (VCRE) operates in the Medical - Pharmaceuticals industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is VCRE's market cap?: Vicore Pharma Holding AB (VCRE) has a market capitalization of approximately $3.27 billion, as of July 22, 2026, based on the most recent share price and shares outstanding.
Does VCRE pay a dividend?: No — Vicore Pharma Holding AB (VCRE) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.